Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.21.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues $ 59,568
Cost of goods sold 104,729
Gross profit (loss) (45,161)
Operating expenses:    
General and administrative 3,960,791 2,225,551
Goodwill impairment 102,000
Professional fees 3,878,006 3,473,300
Depreciation expense 33,610 19,668
Total operating expenses 7,872,407 5,820,519
Operating loss (7,917,568) (5,820,519)
Other income (expense):    
Loss on disposal of fixed assets (4,087)
Interest income 4
Interest expense (47,592) (382,582)
Total other expense (47,592) (386,665)
Net loss (7,965,160) (6,207,184)
Other comprehensive loss:    
Loss on foreign currency translation (36,622) (12,158)
Net other comprehensive loss (8,001,782) (6,219,342)
Series A convertible preferred stock declared ($0.60 per share) (37,236)
Deemed dividend on common stock warrants, series A preferred stock (1,502,330)
Net loss attributable to common shareholders $ (9,541,348) $ (6,219,342)
Weighted average number of common shares outstanding - basic and fully diluted 48,829,160 41,089,784
Net loss per common share - basic and fully diluted $ (0.20) $ (0.15)
Dividends declared per share of common stock $ (0.00) $ (0.00)